![Craig Philips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Philips
Präsident bei
Kineta, Inc. (Washington)
Profil
Craig W.
Philips is the founder of Abacus Bioscience, Inc. He serves as President of Kineta, Inc. since 2013 and as Governor of Kineta Viral Hemorrhagic Fever LLC.
Former positions include Chief Executive Officer & Director at Kv1.3 Therapeutics, Inc., Director at The Cube&, Inc., President at CTI BioPharma Corp.
from 2008 to 2012, Vice President & General Manager at Bayer HealthCare Pharmaceuticals, Inc. in 2008, Vice President & General Manager at Berlex Pharmaceuticals, Inc. from 2006 to 2006, and President & Secretary at Kineta, Inc. from 2024 to 2025.
Education includes undergraduate and MBA from The Ohio State University.
Aktive Positionen von Craig Philips
| Unternehmen | Position | Beginn |
|---|---|---|
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Präsident | 01.01.2013 |
Ehemalige bekannte Positionen von Craig Philips
| Unternehmen | Position | Ende |
|---|---|---|
| KINETA, INC. | Präsident | 30.06.2025 |
Kineta Viral Hemorrhagic Fever LLC
 Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 30.11.2023 |
| CTI BIOPHARMA CORP. | Präsident | - |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Corporate Officer/Principal | 01.04.2008 |
Berlex Pharmaceuticals, Inc. | Corporate Officer/Principal | 01.12.2006 |
Ausbildung von Craig Philips
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CBI Co., Ltd.
 CBI Co., Ltd. Auto Parts: OEMProducer Manufacturing Manufactures and sells of automobile parts | Producer Manufacturing |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Berlex Pharmaceuticals, Inc. | |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Health Technology |
Kineta Viral Hemorrhagic Fever LLC
Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Abacus Bioscience, Inc.
 Abacus Bioscience, Inc. BiotechnologyHealth Technology Develops novel immunotherapeutic for cancer and antiviral diseases | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
